Compare SHFS & PPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | SHFS | PPCB |
|---|---|---|
| Founded | 2015 | 2007 |
| Country | United States | Australia |
| Employees | 41 | N/A |
| Industry | Finance: Consumer Services | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7M | 3.2M |
| IPO Year | N/A | N/A |
| Metric | SHFS | PPCB |
|---|---|---|
| Price | $0.88 | $0.11 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 84.0K | ★ 1.4M |
| Earning Date | 03-30-2026 | 05-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.72 | $0.10 |
| 52 Week High | $9.18 | $10.69 |
| Indicator | SHFS | PPCB |
|---|---|---|
| Relative Strength Index (RSI) | 44.37 | 25.73 |
| Support Level | $0.79 | N/A |
| Resistance Level | $1.03 | $0.40 |
| Average True Range (ATR) | 0.10 | 0.01 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 24.48 | 0.99 |
SHF Holdings Inc is a financial services provider to cannabis-related businesses. It offers reliable access to banking solutions for cannabis, hemp, CBD, and ancillary operators, making communities safer, driving growth in local economies, and fostering long-term partnerships. The group, through its financial institution clients, implements accountability, transparency, monitoring, reporting, and risk mitigation measures while meeting Bank Secrecy Act obligations in line with FinCEN guidance on cannabis-related businesses. Its services include Program Management Support, Customer Generation, Ongoing Program Auditing, and Compliance Monitoring, among others.
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.